Can You Advertise IV Therapy, NAD+ and Hyperbaric Oxygen on Meta and Google?

What this means for you

• Target adults. Meta requires ads for health products and services to target people 18 and over, and Microsoft applies 18 and over to every health ad.
• Drop cure claims. Meta bans claims to cure, heal or eliminate a fixed list of diseases, including cancer, diabetes, Alzheimer's, Parkinson's and autism.
• Keep experimental and regenerative offers out of Google ads. Google bans promotion of speculative or experimental treatments, with biohacking as an example, and of stem cell and PRP therapy except FDA-licensed products.
• Treat any prescription or compounded product under the drug rules, and never call a compounded drug FDA approved.
• Back every health claim with competent and reliable scientific evidence. Testimonials don't count.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs paid ads for clinics that offer IV therapy, NAD+, hyperbaric oxygen and other longevity services. This page sets out the platform and regulator rules that decide whether those ads run. It makes no claim about what any of these therapies do; that belongs to your medical team and each product's regulatory status. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

Why longevity ads get rejected

Low approval rates in this category usually trace back to the claim, not the service. Meta's Health and Wellness policy bars claims, including those from health professionals, to cure, heal or eliminate any of a fixed list of incurable diseases and terminal illnesses: diabetes, herpes, thyroid, psoriasis, Ebola, cancer, autism, Alzheimer's, Parkinson's, ALS and HIV. Meta notes that this does not apply to claims about treating or managing symptoms. The same policy bans clickbait in a health context, such as sensational language or promises of specific outcomes within a set timeframe without disclaimers or qualifiers.

Copy can also fail Meta's personal attributes rule, which bars ads that assert or imply the viewer's physical or mental health. "IV hydration now open in Austin" describes a service. "Tired all the time?" implies something about the person reading it.

Google: experimental treatments and unapproved products

Google's Healthcare and medicines policy doesn't allow promotion of speculative or experimental medical treatments, and its examples are biohacking, do-it-yourself genetic engineering products and gene therapy kits. It also bars promotion of cell and gene therapies, with stem cell therapy, cellular therapy and platelet rich plasma (PRP) among its examples, except FDA-licensed or approved cell or gene therapies promoted in the US by the license holder. A longevity menu that lists stem cells or PRP next to IV drips puts the whole landing page at risk.

Google's Unapproved substances policy bans products that are not government approved but are marketed in a way that implies they're safe or effective for preventing, curing or treating a disease or ailment, and products that imply they're as effective as prescription drugs. Microsoft's policy disallows ads for experimental treatments and requires health claims to be supported by credible scientific evidence, including the source and date of the study where applicable.

Injectables and the drug rules

Whether a drip ingredient or an injection is a prescription drug, a compounded drug or neither is a question for your medical and legal team, and the answer changes the ad. A prescription drug named in an ad, landing page or keyword falls under Google's Restricted drug terms policy, which in the US allows drug terms in ads and landing pages but requires certification to keyword-target them, and under Meta's Drugs and Pharmaceuticals policy, which requires LegitScript certification and Meta's authorization to promote prescription drugs.

If a product is compounded, FDA's statements on compounded drugs apply. FDA's chart of FD&C Act provisions shows that drugs compounded under section 503A are exempt from premarket approval, which is why they are not FDA-approved. FDA's reminders to telehealth companies promoting compounded drugs, written with GLP-1s in mind, list claiming FDA approval, calling a compounded drug the same as an approved one, and claiming it comes from an FDA-approved or FDA-licensed pharmacy as misleading, because FDA does not approve or license any facility.

Hyperbaric oxygen

FDA describes hyperbaric oxygen therapy devices as Class II medical devices cleared through the 510(k) process, and says FDA-cleared devices can be found by searching product code CBF in its 510(k) database. In August 2025 it reminded providers that it is aware of reports of serious injuries and deaths with HBOT devices, including fires. For advertising, that means two things: say FDA-cleared only for a chamber that appears in the 510(k) database, and describe only the uses that clearance covers. Meta's cure list applies to hyperbaric ads as it does to drips.

Claims need evidence

FTC staff's Health Products Compliance Guidance says the same legal principles apply to the marketing of any health-related product, that health claims require substantiation in the form of competent and reliable scientific evidence, and that anecdotal evidence about individual experiences is never sufficient to substantiate claims about a health product's effects. A client's testimonial after a drip can't carry a claim the clinic couldn't make itself.

What MedScale does

MedScale Health builds IV and longevity clinic campaigns around access, process, setting and staff credentials, keeps experimental and regenerative offers off ad landing pages, and checks every claim against the platform rules and the product's FDA status before launch. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No cost per patient is promised. Book the free growth audit at medscale.health/audit for a written plan.